Exercise capacity in patients with heart failure with mildly reduced ejection fraction and preserved ejection fraction

Tran Huu Dat, Duong The Vinh, Tran Thanh Tinh, Tran Thi Bich Dao, Nguyen Van Trung, Nguyen Huu Kieu, Bui Thi Hoai Thu

Main Article Content

Abstract

This study was conducted to assess the exercise capacity of patients diagnosed with heart failure with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HfpEF) based on cardiopulmonary exercise testing (CPET) and the 6-minute walk test (6MWT). In a cohort of 40 patients with heart failure and left ventricular ejection fraction (LVEF) > 40%, the mean VO2max was 13.8 ± 0.5 ml/kg/min, with 47.5% of patients falling below the prognostically significant threshold of 14 ml/kg/min. The mean 6MWT distance was 359.1 ± 8.7 meters, and 10% of patients walked less than 300 meters, indicating significant functional limitation. Inspiratory muscle weakness (IMW) was significantly associated with reduced VO2max (12.5 vs. 14.3, p = 0.0227) and shorter 6MWT distance (331.6 vs. 373.9 meters, p = 0.0091). In multivariate regression analysis, 6MWT distance was an independent predictor of VO2max (β = 0.020, p = 0.027). In conclusion, patients with HFmrEF and HFpEF exhibited markedly reduced exercise capacity, reflected in low VO2max and limited 6MWT distance. These findings highlight the importance of functional assessment for screening and selecting candidates for cardiac rehabilitation programs.

Article Details

References

1. Savarese G, Stolfo D, Sinagra G, et al. Heart failure with mid-range or mildly reduced ejection fraction. Nature Reviews Cardiology. 2022/02/01 2022;19(2):100-116. doi:10.1038/s41569-021-00605-5
2. Reinhardt M, Schupp T, Behnes M, et al. Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction. Journal of Clinical Medicine. 2024;13(17):5151.
3. Solomon SD, Claggett B, Lewis EF, et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. European heart journal. 2016;37(5):455-462.
4. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. New England Journal of Medicine. 2008;359(23):2456-2467.
5. Guazzi M, Wilhelm M, Halle M, et al. Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology. European journal of heart failure. Aug 2022;24(8):1327-1345. doi:10.1002/ejhf.2601
6. Pandey A, Parashar A, Kumbhani DJ, et al. Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction. Circulation: Heart Failure. 2015/01/01 2015;8(1):33-40. doi:10.1161/CIRCHEARTFAILURE.114.001615
7. Malhotra R, Bakken K, D’Elia E, et al. Cardiopulmonary exercise testing in heart failure. JACC: Heart Failure. 2016;4(8):607-616.
8. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2021;42(36):3599-3726.
9. Caraballo C, Desai NR, Mulder H, et al. Clinical Implications of the New York Heart Association Classification. Journal of the American Heart Association. Dec 3 2019;8(23):e014240. doi:10.1161/jaha.119.014240
10. Schoser B, Fong E, Geberhiwot T, et al. Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet journal of rare diseases. Mar 16 2017;12(1):52. doi:10.1186/s13023-017-0598-0
11. Yamada K, Kinugasa Y, Sota T, et al. Inspiratory muscle weakness is associated with exercise intolerance in patients with heart failure with preserved ejection fraction: a preliminary study. Journal of cardiac failure. 2016;22(1):38-47.
12. Society AT, Physicians ACoC. American Thoracic Society/American College of Chest Physicians statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
13. Kim M, Bae S, Park JH, et al. Relative importance of left atrial reservoir strain compared with components of the HFA-PEFF score: a cross-sectional study. Frontiers in cardiovascular medicine. 2023;10:1213557. doi:10.3389/fcvm.2023.1213557
14. Rodolico D, Schiattarella GG, Taegtmeyer H. The lure of cardiac metabolism in the diagnosis, prevention, and treatment of heart failure. Heart Failure. 2023;11(6):637-645.
15. Cavero-Redondo I, Saz-Lara A, Bizzozero-Peroni B, et al. Accuracy of the 6-Minute Walk Test for Assessing Functional Capacity in Patients With Heart Failure With Preserved Ejection Fraction and Other Chronic Cardiac Pathologies: Results of the ExIC-FEp Trial and a Meta-Analysis. Sports medicine - open. Jun 18 2024;10(1):74. doi:10.1186/s40798-024-00740-6
16. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;79(17):e263-e421.
17. Duca F, Zotter-Tufaro C, Kammerlander AA, et al. Gender-related differences in heart failure with preserved ejection fraction. Scientific reports. Jan 18 2018;8(1):1080. doi:10.1038/s41598-018-19507-7
18. Park JH, Hwang IC, Park JJ, et al. Prognostic power of left atrial strain in patients with acute heart failure. European heart journal Cardiovascular Imaging. Jan 22 2021;22(2):210-219. doi:10.1093/ehjci/jeaa013
19. Swank AM, Horton J, Fleg JL, et al. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circulation Heart failure. Sep 1 2012;5(5):579-85. doi:10.1161/circheartfailure.111.965186